Previous 10 | Next 10 |
2024-06-14 12:31:42 ET With the first half of 2024 almost in the books, investors will notice that 10 of the 11 S&P 500 ( SP500 ) sectors are higher on the year and only two segments are topping the YTD return of Wall Street's benchmark index.... Read the full article on Seeki...
2024-06-14 10:24:55 ET Summary Structure Therapeutics Inc. shares surged over 50% on positive GSBR-1290 data, competing with other oral GLP-1R clinical rivals. However, GSBR-1290's efficacy at week 12 fell below Novo Nordisk's amycretin, but still competitive in the obesity treatm...
2024-06-14 08:01:46 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? ...
2024-06-14 05:50:00 ET Novo Nordisk 's (NYSE: NVO) Wegovy currently reigns as the king of the obesity drug market. It generated roughly $4.5 billion in sales last year and will likely rake in even more in 2024. But note the use of the word "currently." Wegovy's market-topping po...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $129.61 on volume of 255,610,868 shares Longeveron Inc. (LGVN) rose 48.6% to $2.69 on volume of 190,987,878 shares PROSHARES TRUST (SQQQ) fell 1.6% to $8.54 on volume of 116,711,722 shares Tesl...
2024-06-13 11:25:22 ET Summary This is a market in which the winners not only keep winning, but they continue to lap the broader market over and over again. And though everyone has been calling for a broadening out of stocks, that's not happening. So until the narrative changes, s...
2024-06-13 09:49:40 ET More on JPMorgan Chase JPMorgan Chase & Co. (JPM) Morgan Stanley US Financials, Payments & CRE Conference JPMorgan Chase: Just By Opening 500 New Branches, It Could Potentially Generate Another $9.11B In Revenues JPMorgan Chase hires fo...
2024-06-13 07:18:52 ET Summary The Schwab U.S. Large-Cap Growth ETF is an excellent alternative to the Invesco QQQ Trust. Its holdings overlap the QQQ's to a considerable degree, but with a much lower fee, and exposure to financials. This makes sense because the Dow Jones Larg...
2024-06-13 02:30:42 ET Summary A difficult period for Pfizer might be coming to an end, as serious setbacks and tough Y/Y comps are in the rearview mirror. The first quarter performance of the commercial business exceeded Street expectations, and the company maintained its full-ye...
2024-06-12 18:34:33 ET Summary At today's FOMC meeting, the Fed held interest rates steady and signaled that it's likely to cut less than the market thinks. This is somewhat surprising given that the econometric models I run are suggesting that the Fed has room to cut. Between...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-18 05:23:00 ET Stock splits can sometimes be an effective way for a company to generate excitement around its stock. It's a sign that the company is doing well, and by lowering the price of the stock through a split, the shares can become more accessible to a wider pool of investo...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...